US: Which vaccine is best? The one you can get first, experts say
Al Jazeera
Some health workers worry that patients’ preferences for coronavirus vaccine brands could slow the rollout of jabs in the United States.
Washington, DC, United States – As the United States ramps up its COVID-19 inoculation campaign, aiming to make vaccines available to all adults by April 19, some doctors and health workers are concerned that brand preferences among potential vaccine recipients could hurt attempts to slow the spread of the virus. Many states across the country are escalating efforts to vaccinate as many people as quickly as possible to mitigate new waves of infections. As of Wednesday, the US administered an average of more than three million doses a day nationwide during the previous seven days, according to Our World in Data. Earlier this week, more than four million people received a shot in a single day, a record high daily number of injections. The US Food and Drug Administration (FDA) has granted authorisation for emergency use to three COVID-19 vaccines that it says are highly effective in preventing infections and severe illnesses from the novel coronavirus.More Related News